Category: Article
Strengthening and transforming the pharmaceutical supply chain
In this exclusive interview, Naser Al Yammahi, Deputy CEO of Hayat Biotech explores challenges facing the pharmaceutical supply chain, medicine shortages and looks at how technology advances will drive supply chain transformation. Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue […]
Read More
AI in Healthcare
In this special report on AI in healthcare, CNN BA sat down with our Deputy CEO, Naser Al Yammahi, in addition to hashtag #HayatBiotech’s Senior Medical Advisor, Dr. Nawal Al Kaabi, to get an in-depth perspective on the practical applications of using artificial intelligence when conducting clinical trials. Among a multitude of advantages, the report […]
Read More
Hayat Biotech hosts Revolutionizing Life Sciences from Abu Dhabi discussion panel Copy
Abu Dhabi, UAE, 06 June 2023: Hayat Biotech, a leading biotechnology company headquartered in the UAE, has invited national and international healthcare experts, renowned academics, and representatives from the Department of Health – Abu Dhabi (DoH) to discuss the future of the UAE healthcare system and the role of Abu Dhabi on the international stage. […]
Read More
COLLABORATION AND DATA WILL BE KEY IN TACKLING THE NEXT PANDEMIC
By Dr. Nawal Al Kaabi, Senior Medical Advisor at Hayat Biotech, a leading UAE-based biotechnology and life sciences company. Earlier this month, the World Health Organization officially declared that COVID-19 no longer represents a global health emergency. While its emergency status may be over, this is not the time to put our foot on the […]
Read More
Naser Al Yammahi, Deputy CEO Of Hayat Biotech: Transforming Healthcare Through Advanced Manufacturing
Naser Al Yammahi, Deputy CEO of Hayat Biotech Naser Al Yammahi, Deputy CEO of U.A.E.-based Hayat Biotech, explains the importance of innovation to elevating human health and his company’s approach to pushing scientific frontiers with clinical trials. From being the director of the U.A.E. Ministry of State Office to the deputy CEO of Hayat Biotech, how […]
Read More